Tuesday, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) announced two tools to streamline the drug development process for pharmaceutical and biotech companies. Building on its partnership with Alphabet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback